Cargando…

Implications of the European Association of Urology Recommended Risk Assessment Algorithm for Early Prostate Cancer Detection

The 2021 European Association of Urology recommendations for early prostate cancer detection included a risk-based algorithm. Risk assessment methods are proposed to prevent excessive use of prostate magnetic resonance imaging (MRI) and biopsy, simultaneously reducing overdiagnosis and overtreatment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Israël, Bas, Hannink, Gerjon, Barentsz, Jelle O., van der Leest, Marloes M.G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Brief Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278493/ https://www.ncbi.nlm.nih.gov/pubmed/35845549 http://dx.doi.org/10.1016/j.euros.2022.06.006

Ejemplares similares

Clinical implementation of pre‐biopsy magnetic resonance imaging pathways for the diagnosis of prostate cancer
por: Israël, Bas, et al.
Publicado: (2021)

Can Exercise Adaptations Be Maintained in Men with Prostate Cancer Following Supervised Programmes? Implications to the COVID-19 Landscape of Urology and Clinical Exercise
por: Lopez, Pedro, et al.
Publicado: (2020)

Clinical use of the SelectMDx urinary-biomarker test with or without mpMRI in prostate cancer diagnosis: a prospective, multicenter study in biopsy-naïve men
por: Hendriks, Rianne J., et al.
Publicado: (2021)

Exploring the Diversity and Predictors of Histopathological Findings Across the European Association of Urology Guidelines Office Rapid Reaction Group Priority Groups for Patients with Renal Tumors: Implications for Individualized Prioritization of Renal Cancer Care
por: Campi, Riccardo, et al.
Publicado: (2021)

How to follow the new EU Council recommendation and improve prostate cancer early detection: the Prostaforum 2022 declaration
por: Májek, Ondřej, et al.
Publicado: (2023)

Digital Therapeutics in Urology: An Innovative Approach to Patient Care and Management
por: Rodler, Severin, et al.
Publicado: (2023)

Urology Residency Training at the Time of COVID-19 in Italy: 1 Year After the Beginning
por: Amparore, Daniele, et al.
Publicado: (2021)

Estimating the Impact of COVID-19 on Urology: Data from a Large Nationwide Cohort
por: Lewicki, Patrick, et al.
Publicado: (2021)

Telemedicine and Smart Working: Recommendations of the European Association of Urology
por: Rodriguez Socarrás, Moises, et al.
Publicado: (2020)

Are we ready to adopt the European Association of Urology recommendations on multiparametric magnetic resonance imaging in the early detection of prostate cancer?
por: Thangasamy, Isaac A., et al.
Publicado: (2019)

A Snapshot from the Department of Urology in Bergamo Evaluating the Timeline of the SARS-CoV-2 Outbreak: Which Patients Are We Missing?
por: Roscigno, Marco, et al.
Publicado: (2020)

Major Urological Cancer Surgery for Patients is Safe and Surgical Training Should Be Encouraged During the COVID-19 Pandemic: A Multicentre Analysis of 30-day Outcomes
por: Tan, Wei Shen, et al.
Publicado: (2021)

The Early Effects of Rapid Androgen Deprivation on Human Prostate Cancer
por: Shaw, Greg L., et al.
Publicado: (2016)

Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers
por: Adamski, Jakub, et al.
Publicado: (2010)

Head-to-Head Comparison of (68)Ga-Prostate-Specific Membrane Antigen PET/CT and Ferumoxtran-10–Enhanced MRI for the Diagnosis of Lymph Node Metastases in Prostate Cancer Patients
por: Schilham, Melline G.M., et al.
Publicado: (2021)

Telemedicine and smart working: Spanish adaptation of the European Association of Urology recommendations()
por: Gómez Rivas, J., et al.
Publicado: (2020)

Current Routine Testosterone Immunoassays Are Unsuitable for Lowering the General Castration Cutoff Recommendation to <0.7 nmol/l (20 ng/dl)
por: van Rossum, Huub H., et al.
Publicado: (2023)

Decentralised elements in clinical trials: recommendations from the European Medicines Regulatory Network
por: Al, Monique, et al.
Publicado: (2023)

Addition of Prostate Volume and Prostate-specific Antigen Density to Memorial Sloan Kettering Cancer Center Prostate Cancer Nomograms
por: Tzeng, Michael, et al.
Publicado: (2021)

Standardization of Multiparametric Prostate MR Imaging Using PI-RADS
por: Bomers, Joyce G. R., et al.
Publicado: (2014)

PI-QUAL v.1: the first step towards good-quality prostate MRI
por: de Rooij, Maarten, et al.
Publicado: (2021)

External Validation of a Prediction Model for Side-specific Extraprostatic Extension of Prostate Cancer at Robot-assisted Radical Prostatectomy
por: Veerman, Hans, et al.
Publicado: (2022)

Time to Implement the European Society of Cardiology 0/1-Hour Algorithm
por: Chiang, Cho-Han, et al.
Publicado: (2020)

Design and construction of translational medicine platform for urologic oncology
por: Xu, Yong, et al.
Publicado: (2012)

Implementation of 4Kscore as a Secondary Test Before Prostate Biopsy: Impact on US Population Trends for Prostate Cancer
por: Scuderi, Simone, et al.
Publicado: (2023)

European training in urology (ENTRY): quality‐assured training for European urology residents
por: Buffi, Nicolò, et al.
Publicado: (2022)

Prostate Cancer Risk by BRCA2 Genomic Regions
por: Nyberg, Tommy, et al.
Publicado: (2020)

Physician Dispensing Among Urology Practices and the Use of Abiraterone or Enzalutamide for Men With Advanced Prostate Cancer
por: Lai, Lillian Y, et al.
Publicado: (2022)

Second Reply to Letter to the Editor re: “Clinical utility of the Prostate Health Index (phi) for biopsy decision management in a large group urology practice setting”
por: White, Jay, et al.
Publicado: (2019)

What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021
por: Turco, Fabio, et al.
Publicado: (2022)

Addition of a Genetic Risk Score for Identification of Men with a Low Prostate-specific Antigen Level in Midlife at Risk of Developing Lethal Prostate Cancer
por: Ma, Chaoran, et al.
Publicado: (2023)

Aggressive Prostate Cancer at Presentation Following Solid Organ Transplantation
por: Singh, Zorawar, et al.
Publicado: (2022)

Single-lesion Prostate-specific Membrane Antigen Protein Expression (PSMA) and Response to [(177)Lu]-PSMA-ligand Therapy in Patients with Castration-resistant Prostate Cancer
por: Stangl-Kremser, Judith, et al.
Publicado: (2021)

Erratum: Correction of Error in Result: Urological Problems in Patients with Menkes Disease
por: Kim, Mi Young, et al.
Publicado: (2019)

Ultra‐small superparamagnetic iron oxides for metastatic lymph node detection: back on the block
por: Fortuin, Ansje S., et al.
Publicado: (2017)

Using a Recurrent Neural Network To Inform the Use of Prostate-specific Antigen (PSA) and PSA Density for Dynamic Monitoring of the Risk of Prostate Cancer Progression on Active Surveillance
por: Sushentsev, Nikita, et al.
Publicado: (2023)

Confirmation by Early Oncologic Outcomes After Surgery of the Accuracy of Intermediate-risk Prostate Cancer Classification Based on Magnetic Resonance Imaging Staging and Targeted Biopsy
por: Manceau, Cécile, et al.
Publicado: (2020)

Patterns of Care and Treatment Outcomes in Locoregional Squamous Cell Carcinoma of the Prostate
por: Hutten, Ryan J., et al.
Publicado: (2021)

Mobile PSA: A Novel Telehealth Tool for Prostate Cancer Follow-Up
por: Bergroth, Robin, et al.
Publicado: (2021)

Micro-ultrasound Versus Magnetic Resonance Imaging in Prostate Cancer Active Surveillance
por: Albers, Patrick, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_259eitcf7en657nagj9aqudhlu